Progressive kidney fibrosis contributes greatly to end-stage renal failure, and no specific treatment is available to preserve organ function. During renal fibrosis, myofibroblasts accumulate in the interstitium of the kidney, leading to massive deposition of extracellular matrix and organ dysfunction. The origin of myofibroblasts is manifold, but the contribution of an epithelial-tomesenchymal transition (EMT) undergone by renal epithelial cells during kidney fibrosis is still debated. We show that the reactivation of Snai1 (encoding snail family zinc finger 1, known as Snail1) in mouse renal epithelial cells is required for the development of fibrosis in the kidney. Damage-mediated Snail1 reactivation induces a partial EMT in tubular epithelial cells that, without directly contributing to the myofibroblast population, relays signals to the interstitium to promote myofibroblast differentiation and fibrogenesis and to sustain inflammation. We also show that Snail1-induced fibrosis can be reversed in vivo and that obstructive nephropathy can be therapeutically ameliorated in mice by targeting Snail1 expression. These results reconcile conflicting data on the role of the EMT in renal fibrosis and provide avenues for the design of novel anti-fibrotic therapies.
a r t i c l e s
Chronic kidney disease (CKD), the progressive deterioration of kidney function, is characterized by glomerulosclerosis (a form of kidney scarring) and tubulo-interstitial fibrosis, regardless of the initial cause of the renal disease. Thus kidney fibrosis is a common feature of CKD and contributes markedly to end-stage renal failure 1 . The only treatment available is the replacement of renal function by dialysis or kidney transplantation, which together, in 2009, represented a cost of over $40 billion in the United States 2 .
The embryonic development of the renal system involves several rounds of EMTs and the reverse process, mesenchymal-to-epithelial transitions (METs) 3 . SNAI1, a potent EMT inducer during embryonic development and tumor progression 4 , is expressed in the precursors of the renal epithelial cells. But its expression is downregulated upon epithelial differentiation and maintained in a silent state during adulthood 5 , as the suppression of epithelial plasticity is crucial to the maintenance of healthy tissue architecture and homeostasis. We previously showed that activation of Snail1 in renal epithelial cells leads to renal fibrosis and renal failure in an inducible transgenic mouse model (Snail1-ERT2) 5 . Snail1 is also reactivated in mice that have been subjected to unilateral ureteral obstruction (UUO) [6] [7] [8] , a standard model for progressive renal fibrosis 9 , and in fibrotic lesions obtained from people who have undergone nephrectomy 5 . Thus, Snail1 reactivation in adult mouse kidneys is sufficient to induce renal fibrosis, and kidney fibrosis is associated with SNAIL1 activation both in animal models and in humans. However, those observations do not address the question of whether Snail1 reactivation, and, in turn, an EMT-like program, is required for renal fibrosis to develop. Although initial cell-fate tracing experiments described a substantial contribution of renal epithelial cells to myofibroblasts 10 , subsequent studies could not find labeled epithelial cells in the interstitium in animal models of renal fibrosis [11] [12] [13] . Here we directly assess the role of Snail1 and the EMT process in kidney fibrosis and show that the reactivation of Snail1 is not only sufficient, but also required, for the development of this pathology. We show that Snail1 reactivation in renal epithelial cells triggers a partial EMT that, without directly generating interstitial myofibroblasts, relays crucial signals for the differentiation of myofibroblasts and markedly contributes to the inflammatory response. The partial EMT program leads to dedifferentiation of renal epithelial cells and promotes kidney fibrosis but preserves the integrity of the renal tubules. Here we show that the fibrosis response can be reversed in vivo by inhibition of Snail1 expression in mouse models of kidney injury.
RESULTS

Snail1 depletion ameliorates UUO-induced fibrosis
To directly assess the contribution of Snail1 reactivation in epithelial cells to renal fibrosis, we crossed Snai1 fl/fl mice 14 with a strain bearing the Ksp1.3-Cre transgene 15 . Ksp-cadherin (cadherin-16, encoded by Cadh16) is a kidney-specific cadherin that is expressed in renal epithelial cells both in the cortex and in the medulla. The resulting strain, Ksp1.3-Cre; Snai1 fl/fl , referred to as SFKC hereafter (Supplementary Fig. 1 ), impedes Snail1 expression in cadherin-16-positive cells. Snail1 expression is silent in the adult kidney, but it is reactivated in the cortex and in the medulla after subjection to UUO (Supplementary Fig. 1c) . During renal development, Snail1 is a strong Cadh16 repressor 5 , and it is only when Snai1 is downregulated that renal cells express cadherin-16 and epithelialization occurs. Because Snail1 is silenced in the adult mouse, preventing Snail1 activation in cadherin-16-positive cells in the kidney does not have any impact in healthy mice. As expected, although Snail1 was highly reactivated in the kidney upon subjection to UUO, this was not the case in recombined renal epithelial cells in SFKC mice (Fig. 1a-c) . We analyzed overall morphology, collagen deposition and expression of α-smooth muscle actin (α-SMA, encoded by Acta2) and vimentin (encoded by Vim) 7 d or 15 d after UUO and found that kidneys from SFKC mice were protected from the development of overt fibrosis, although signs of tubular distension resulting from the obstruction were readily evident (Fig. 1d,e and Supplementary Fig. 2a,b) . We confirmed the attenuation of fibrosis by analyzing the expression of epithelial and mesenchymal markers, and this was particularly evident 2 weeks after the mice were subjected to UUO (Fig. 1f) . Quantification of Sirius red staining (Fig. 1g) showed a 35% reduction in fibrosis in the cortex of obstructed kidneys from SFKC mice compared to obstructed kidneys from WT or control (Ksp1.3-Cre only) mice ( Fig. 1g and Supplementary Fig. 3a,b) . In our SFKC model, Snail1 reactivation was also prevented in the collecting ducts, and we observed a much-better-preserved morphology and less collagen deposition in the medulla than in the kidneys of WT animals ( Supplementary Fig. 3c ), indicating that overall protection from fibrotic degeneration is higher than that reflected by the quantification of Sirius red staining in the cortex. We next assessed the contribution of renal epithelial cells to the interstitial cell populations after UUO in our system. We generated a mouse model harboring Cre-loxP-mediated expression of the Tomato fluorescent protein driven by the Ksp1.3 promoter (Ksp1.3-Cre; Rosa-LSL-TdTomato). These mice allow visualization and fate mapping of renal epithelial cells. Notably, we could not detect any tdTomato + cells in the interstitium 7 d after obstruction (Supplementary Fig. 4a ) and found less than 1% of the tdTomato + cells after 15 d (Fig. 2a) . One of the rare cells that left the tubules is shown in Supplementary Figure 4b . Thus, renal epithelial cells do not delaminate from the tubules to contribute to myofibroblasts or other interstitial cells, which is also in keeping with the observation that the total number of tubular cross sections did not differ between kidneys from WT and those from SFKC mice 15 d after UUO (Fig. 2b) , indicative of tubular integrity. Snail1 expression was reactivated after UUO in more than 80% of tubular cells and also in activated interstitial cells, as reported in cancer models in mice 16 (Fig. 2c) .
Although tubular epithelial cells did not directly contribute to the myofibroblast population, UUO provoked the downregulation of the epithelial markers Cadh1 and Cadh16 (Fig. 1f) together with the loss of apicobasal polarity and cell differentiation as indicated by the disappearance of lectin expression 17 in renal epithelial cells in which Snail1 has been reactivated (Fig. 2a,d ). Fifteen days after UUO, some tubular epithelial cells (around 30%) also activated the expression of α-SMA (Fig. 2a) and that of the gene encoding collagen I (Col1a1) ( Supplementary 4c) ; the latter is a downstream target of Snail1 in the kidney 5 .
Our data indicate that, after renal injury, the tubular epithelial cells, in spite of Snail1 reactivation, continue to display integration into the tubular tissue. Therefore, it seems that UUO-induced Snai1 reactivation triggers only a partial EMT in both cortical and medullar renal epithelial cells, which do not acquire an invasive phenotype. This leads to damaged tubules and collecting ducts. As all of these effects are highly attenuated in the kidneys from SFKC mice, in which renal epithelial cells cannot reactivate Snail1 expression (Fig. 1,  Fig. 2d and Supplementary Figs. 2b, 4 and 5) , we conclude that Snail1 reactivation in renal epithelial cells has an important effect on the development of fibrosis.
Snail1 reactivation promotes fibrogenesis and inflammation
Our results indicate that damaged Snail1-expressing renal epithelial cells, despite being integrated in the tubules, can send signals to the interstitium, as the α-SMA + myofibroblast population is highly reduced in obstructed kidneys from SFKC mice (Fig. 1e) . Injured epithelial cells produce transforming growth factor β (TGF-β, encoded by Tgfb1)-containing exosomes that promote the proliferation and activation of interstitial fibroblasts 18 , and TGF-β signaling is also important for the differentiation of myofibroblasts from bone marrow-derived mesenchymal stem cells 18 . In relation to this, we found that both Tgfb1 expression and the activation of TGF-β signaling in the obstructed kidney, measured by staining with antibodies specific to phosphorylated Smad family member 2 (phospho-Smad2), were dependent on Snail1 reactivation in renal epithelial cells ( a r t i c l e s 9 9 2 VOLUME 21 | NUMBER 9 | SEPTEMBER 2015 nature medicine and Supplementary Fig. 5a ), an observation that is compatible with the role of Snail1 as an activator of the TGF-β pathway in cancer cells 19 . Thus, the lower levels of TGF-β expression and signaling in obstructed kidneys from SFKC mice explains the decrease in the α-SMA + population ( Fig. 1e and Supplementary Fig. 2b ).
As TGF-β is also involved in the recruitment of macrophages 20 , we examined expression of the pan-macrophage marker F4/80 and observed that macrophage colonization in obstructed kidneys from SFKC mice was highly attenuated compared to colonization in the kidneys of WT mice, as was the overall inflammatory response, as indicated by the lower levels of nuclear phosphorylated NF-κB (pNF-κB) in tubular cells (Fig. 3a) . Taking advantage of the LacZ reporter allele in our SFKC mice, we confirmed that pNF-κB labeling was absent in tubules that had recombined (X-gal-positive tubules) and that were therefore not competent to reactivate Snail1 (Supplementary Fig. 5b ).
We next analyzed the F4/80 macrophage population and identified polarized M2 macrophages in obstructed kidneys from WT mice (CD163 + ; Fig. 3a) , the macrophage type that is enriched in the tumor microenvironment 21 . Given that UUO induces a robust inflammatory response and Snail1 can induce the expression of some inflammatory cytokines 22 , we compared the levels of cytokines present in obstructed kidneys. We found that the levels of several types of pro-inflammatory cytokines were lower in kidneys from SFKC mice than in those from WT mice, indicating that Snail1 reactivation in tubular cells impinges on the inflammatory response. These cytokines included tumor necrosis factor α (TNF-α encoded by Tnf ) and several chemokines that are associated with macrophage recruitment (Fig. 3b) . Snail1 has been shown to enhance the recruitment of M2 macrophages to the tumor site by directly activating the transcription of the Tnf, Ccl2 and Ccl5 genes in tumor cells 23 . As all three of these are included among the cytokines present in lower amounts in obstructed kidneys from SFKC mice, we checked their expression levels after subjection to UUO. Tnf, Ccl2 and Ccl5 mRNA levels were all higher in the obstructed kidneys than in the control contralateral kidneys 7 d after UUO, but Tnf expression was already higher 3 d after surgery (Fig. 3c) . When we compared WT to SFKC mice, we found differences in Ccl5 levels starting from 7 d after UUO and these differences were apparent for all three cytokines after 15 d (Fig. 3c) . Thus, Snail1 reactivation is required to sustain inflammation, although the early inflammatory response seems to be Snail1-independent for at least some of the cytokines (Fig. 3b,c) . Nevertheless, some early inflammatory responses also require Snail1 reactivation, as indicated by the higher abundance of nuclear pNF-κB in tubular cells and the higher Tgfb1 expression in obstructed kidneys from WT versus SFKC mice 3 d after surgery (Fig. 3d,e) . Together, these data indicate that UUO-induced fibrosis concurs with a partial EMT of renal epithelial cells that is mediated by the reactivation of Snail1. Tubular cells do not engage in the delamination and invasion program and, therefore, do not directly contribute to interstitial fibroblasts. However, this Snail1-induced partial EMT impinges on the TGF-β and NF-κB pathways and on cytokine production to promote myofibroblast differentiation, fibrogenesis, macrophage recruitment and sustained inflammation, all of which are required for the development and progression of organ fibrosis.
Snail1 depletion attenuates folic acid-induced fibrosis
We extended our studies to an additional model of renal fibrosis, folic acid (FA)-induced nephropathy 24 . As expected, a single intraperitoneal injection of FA induced a patchy interstitial fibrosis by 4 weeks after injection. We detected all signs of overt fibrosis, Mean pixel density (fold)
**** **** *** ** ** for groups of three mice. *P < 0.5, **P < 0.1, ***P < 0.01, ****P < 0.0001; two-way ANOVA followed by Tukey's multiple comparison test. Scale bars, 50 µm.
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including altered tubular morphology, loss of epithelial differentiation, a numerous myofibroblast population, excessive collagen deposition and macrophage colonization in WT mice ( Fig. 4a and Supplementary Fig. 6a ).
Quantitative analysis of epithelial and mesenchymal marker transcripts in kidneys from FA-treated WT mice compared to vehicletreated WT mice confirmed the increase in Snai1, Col1a1, Vim and Acta2 mRNA levels, and the decrease in Cadh1 and Cadh16 mRNA levels (Fig. 4b) . The expression of the main fibrogenic (that is, Tgfb1) and inflammatory signals (that is, Tnf) was also increased in FA-treated versus vehicle-treated WT mice (Fig. 4b) . Notably, all of these changes were highly reduced in FA-treated SFKC mice when compared to FA-treated WT mice (Fig. 4 and Supplementary Fig. 6 ). The analysis of cytokines also confirmed a robust reduction in the levels of pro-inflammatory cytokines, including TNF-α, CCL2 and CCL5 in FA-treated SFKC mice versus FA-treated WT mice (Fig. 4c) . We observed a 62% reduction in fibrosis in the kidney cortices of these mice (Fig. 4d) and the medulla was also protected (Fig. 4a  and Supplementary Fig. 6b) indicating that, even more pronounced than after UUO, the reactivation of Snail1 in renal epithelial cells is crucial for the development of FA-induced fibrosis.
Established fibrosis can be ameliorated in vivo
Embryonic and cancer cells present a high degree of epithelial plasticity in terms of the EMT and its reverse process, MET 25 . To examine whether some plasticity exists in fibrotic tissues, we used the renal epithelial cell-specific Snail1-ERT2 fibrosis model that we generated previously 5 . In this model, Snail1 is activated by tamoxifen-induced nuclear translocation of the protein and deactivated upon tamoxifen withdrawal (Supplementary Fig. 7) . We first confirmed that in MDCK Snail1-ERT2 cells treated with tamoxifen, Snail1 translocated to the nucleus and the cells underwent an EMT. After tamoxifen removal, and concomitantly with the absence of nuclear Snail1, the cells reverted to an epithelial phenotype (Supplementary Fig. 7 ).
Next, we tested whether Snail1-induced fibrosis could be attenuated in vivo after the disease was established (Fig. 5a) . In Snail1-ERT2 mice, as in cultured cells, Snail1 protein efficiently shuttled from the cytoplasm to the nucleus upon tamoxifen administration a r t i c l e s 9 9 4 VOLUME 21 | NUMBER 9 | SEPTEMBER 2015 nature medicine and was detected in the cytoplasm again after tamoxifen removal (Fig. 5b) . Fibrosis developed after 8 weeks of tamoxifen exposure in the Snail1-ERT2 model when compared to WT mice ( Fig. 5 and Supplementary  Fig. 8 ) as indicated by histology, Sirius red staining and the expression of mesenchymal and epithelial markers detected either using immunostaining or through gene-expression analyses (Fig. 5c,d and Supplementary Fig. 8a ). Snail1-induced fibrosis also concurred with the activation of Tgfb1 expression and an increase in the inflammatory response (as measured by levels of nuclear pNF-κB) and macrophage recruitment (Fig. 5c,d ). All of these features were highly attenuated 8 weeks after tamoxifen removal, concomitant with the translocation of Snail1 back to the cytoplasm. Particularly, collagen deposition, mesenchymal markers, Tgfb1 levels and inflammation returned almost to basal levels ( Fig. 5c,d ). Sirius red staining in the renal cortex showed a reversion of 56% in overall fibrosis (Fig. 5e) and, notably, the glomerular filtration rate, as assessed by creatinine clearance, also shifted back to normal after having decreased upon Snail1 reactivation (Supplementary Table 1 ). Plasma levels of creatinine were also compatible with this. Together, these data show that Snail1-induced fibrosis can be ameliorated in vivo. However, this experimental design does not address whether renal fibrosis that developed in response to natural stimuli, including damage, could also be ameliorated by inhibiting Snail1. Thus, we next therapeutically inhibited Snail1 function in the UUO model. Seven days after UUO, once the mice had already developed fibrosis (Fig. 1b and Supplementary Fig. 2b ), we systemically injected two different vivo-morpholinos (MOs) designed to target a splicing site in the Snai1 mRNA (Snail1-MO1 and Snail1-MO2; Fig. 6a,  Supplementary Fig. 9 and Online Methods). Targeting the splicing site allowed us to assess the efficacy of the MO in blocking Snail1 expression in each individual mouse, and compare the degree of blockade with the progression of fibrosis. The blockade was assessed by testing the levels of the correctly spliced isoform and those of the isoform in which exon 2 was missing ( Fig. 6 and Supplementary  Fig. 9 ). In Figure 6 , we show a control mouse and mouse #5, in which the MO prevented normal Snai1 splicing ( Supplementary  Fig. 9a ). In this experimental setting, Snail1 inhibition should not be restricted to tubular cells. When we compared mice that had been and Cadh16 abundance upon Snail1 activation (2; +TAM) and deactivation after 8 weeks of tamoxifen removal (3; +TAM −TAM). Data are normalized to vehicle-treated kidney levels (1; −TAM) and represent mean ± s.e.m. for groups of four mice. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; one-way ANOVA followed by Tukey's multiple comparison test. (e) Morphometric analysis of cortical interstitial fibrosis by quantification of Sirius red staining. Data are shown relative to vehicle treated controls (4 mice per group). **P < 0.01, ***P < 0.001, **** P < 0.0001; one-way ANOVA followed by Tukey's multiple comparison test. Error bars show means ± s.e.m. Scale bars, 50 µm.
subjected to UUO for 7 d and then treated with either the control MO (Control-MO) or the Snail1-MOs, we observed that Snail1 inhibition blocked the progression of UUO-induced fibrosis. Kidneys from Snail1-MO-treated mice presented a recovered morphology, less collagen deposition and lower expression of vimentin and α-SMA (Fig. 6b) . Similarly, expression analysis indicated that Snai1, Snai2 and Vim mRNA levels were significantly lower and Cadh1 and Cadh16 levels higher in Snail1-MO treated mice than were those in obstructed kidneys from mice injected with Control-MO (Fig. 6c) . Furthermore, as observed in our analyses of the SFKC mice, Snail1 had a marked effect on Tgfb1 expression, macrophage colonization and inflammation (Fig. 6b,c) , as all these responses were highly attenuated upon Snail1 inhibition. Further, quantification of cortical fibrosis revealed a reduction of 57% after treatment with Snail1-MO versus Control-MO (Fig. 6d) . This attenuation is specific to Snail1 depletion because it did not occur after the injection of Snail1-MO1 in mice in which the MO did not efficiently block normal mRNA splicing (Supplementary Fig. 9 ). In summary, this data indicate that Snail1 inhibition can markedly attenuate established UUO-induced fibrosis in mice.
DISCUSSION CKD can result from urinary obstruction, autoimmune disorders, unresolved inflammation or deterioration of transplants 1 , progressing irreversibly to end-stage renal disease that requires dialysis or kidney transplantation. No specific therapy is available to recover organ function, and the cellular mechanisms that drive interstitial fibrosis are still under debate; results have conflicted, assigning either an important or a negligible role to tubular EMT in the progression of renal fibrosis [10] [11] [12] [13] 26, 27 . In addition, inflammatory cytokines and cells are major effectors of the chronic disease 20, 28 , but the mechanisms by which chronic inflammation impinges on fibrogenesis still remain unclear. Understanding this link is key to the design of therapeutic strategies that could halt the progression of CKD 29 . Using renal epithelial-specific mouse models, and, in particular, modifying Snail1 expression in medullar and cortical renal-fibrosis epithelial cells, we provide evidence of the contribution of EMT to and the link between inflammation and fibrosis. With respect to the EMT, we show that (i) a partial EMT of renal epithelial cells is activated in the event of renal damage, (ii) these damaged cells remain integrated in the tubules while still relaying fibrogenic and inflammatory signals that lead to the progression of the disease and (iii) both fibrogenesis and inflammation require the activation and maintenance of the potent EMT-inducer Snail1. Therefore, our results highlight the importance of an EMT-like program in renal epithelial cells for the development of fibrosis. They also reconcile previous conflicting results on the role of EMT [10] [11] [12] in this process, confirming the limited contribution of a full EMT program that delivers transformed epithelial cells to the interstitium 13 . Importantly, the partial EMT that is undergone by renal epithelial cells and the persistence of the damaged tubules explains the high degree of cell plasticity that we observed in vivo, as we show that Snail1 inactivation in a epithelial-specific Snail1-induced fibrosis model leads to the recovery of renal morphology and function. Furthermore, we also show that inhibition of Snail1 once fibrosis has been established can also ameliorate the disease. In relation to this, it is worth noting that Snail1 provides protection from cell death and decreases proliferation 30 , suggesting that Snail1 reactivation in tubular cells would make cells survive and stay in the tubules, albeit in an undifferentiated state. Subsequent Snail1 inhibition can help in the resolution of fibrosis by promoting the reversion of the damaged tubule cells to an epithelial phenotype and an increase in proliferation. During TGF-β-induced EMT in cancer cells, the mutual antagonism between Snail1 and miR- 34 (refs. 31,32) has been recently considered as a reversible switch, pointing to the possibility of reversion to the epithelial phenotype in cancer cells 32 , and miR-34c has been shown to attenuate UUO-induced fibrosis 33 . In cases of very advanced human renal fibrosis, in which there is evidence of tubular atrophy, reversibility may be compromised. Although further investigation to assess the maximum degree of reversibility and the appropriate timing for intervention is warranted, our data encourage the design of anti-EMT by means of anti-Snail1 therapeutic strategies for the treatment of renal fibrosis.
Our data also help to better distinguish type 2 EMT, previously ascribed to fibrosis and wound healing, from type 3 EMT 34 , which is associated with cancer cell delamination from the primary tumor. We see a partial EMT occurring in the type 2 condition, in which damaged adult epithelial cells remain confined to their tissue of origin, without engaging in the delamination and invasion programs. The EMT in cancer (type 3) endows cells with the ability to invade adjacent territories and to intravasate blood vessels to later populate distant organs 25 .
With regard to the link between fibrosis and inflammation, we find that it also relies on the reactivation and, particularly, the maintenance of Snail1 expression, in epithelial cells. UUO induces the activation of TGF-β and NF-κB signaling pathways, which are key for fibrogenesis and inflammation, respectively, and are both crucial drivers of CKD and other fibrotic processes 35, 36 . The initial inflammatory response after UUO leads to TNF-α production, which induces the activation of NF-κB 34 . In addition to inflammation, NF-κB induces Snai1 transcription and the stabilization of the Snail1 protein 37 . TGF-β is first secreted to control the inflammatory response, but in the context of chronic injury as in fibrosis, it becomes fibrogenic and the most potent Snai1 inducer 4 . Thus, both signaling pathways converge on the activation of Snail1, and Snail1 activation and maintenance of its expression are required for the progression of fibrogenesis and for sustained inflammation (Supplementary Fig. 10) . Thus, Snail1 establishes positive feedback loops that reinforce both the fibrogenic and inflammatory responses. As such, although we have not directly targeted TGF-β, we show that Snail1 is required for the maintenance of Tgfb1 expression and signaling. Compatible with the establishment of feedback loops, we show that Snail1 mediates the induction of inflammatory cytokines and of TGF-β signaling as observed in cancer cells 19, 22, 23, 36 . Interestingly, the inflammatory microenvironment in fibrosis seems similar to that in tumors. Altogether, this explains why, in the absence of Snail1 reactivation in tubular cells-as in our SFKC model-both fibrogenesis and inflammation are highly attenuated, indicating that the partial EMT program activated by Snail1 in renal epithelial cells is instrumental in the progression of renal disease.
Given the previous observations, Snail1 should be a promising therapeutic target. We find that after UUO, Snail1 inhibition by systemic injection of antisense oligonucleotides very significantly ameliorates fibrosis. Inhibiting EMT or inflammation by downregulation of either TGF-β (refs. 38,39) or NF-κB 40, 41 signaling pathways has provided hope for anti-fibrotic treatments, but the pleiotropic roles of both pathways, particularly the associated beneficial effects, limit the potential use of their inhibitors in systemic administration protocols 42, 43 . Given that Snail1 is maintained almost silently in healthy adult tissues 5 , its inhibition should not cause undesirable side effects. Our data also provide a window of opportunity for the EMT inhibitors that are currently being developed for anti-metastatic therapies and have been recently challenged by the demonstration that cancer cells need to revert to the epithelial phenotype for successful metastatic colonization 44, 45 . As such, inhibiting EMT in cancer patients could be counterproductive 25 . By contrast, the mesenchymal phenotype is the end stage in organ fibrosis and reversion to the epithelial state should thus be fully beneficial. We propose that Snail1 is located at the center of a 'core' pathway in fibrosis, defining core as a pathway that, when targeted, is sufficient to limit the progression of the disease 42 . In summary, inhibiting an EMT, and Snail1 in particular, can be regarded as a safe strategy for ameliorating fibrosis, especially for fibrotic processes in which inflammation plays an important part in the progression of the disease.
METhODS
Methods and any associated references are available in the online version of the paper. estimate of glomerular filtration rate, was calculated from plasma and urine creatinine concentration and urinary flow using standard formulae.
Morpholino oligomer and in vivo treatment. The oligonucleotides sequences 5′-TGAACTCTGCGGGAAGAGAAGAGAC-3′ VM1 against the boundary sequences of the intron 1 and exon 2 and 5′-GCTATGCACACTCACTCACC AGTGT-3′ VM2 against the boundary sequences of the exon and intron 2 of the Snai1 gene were synthesized as morpholinos (by Gene Tools). Vivomorpholinos were made by conjugation of an unmodified morpholino with a synthetic scaffold featuring eight guanidinium head groups. A control antisense that targets a human β-globin intron mutation 5′-CC TCTTACCTCATTACAATTTATA-3′ was used as vivo-morpholino standard control, VMC. C57/Bl6J male mice aged 8 weeks were subjected to UUO, and 7 d after obstruction, they were injected every other day until day 15. A solution containing vivo-morpholinos in saline (100 µl; 6 mg MO per kg) was injected in the tail vein of the corresponding mice.
Quantification. Sirius red. Renal sections 5 µm thick were stained with Sirius red to evaluate the area occupied by collagen fibrils. From each kidney, a total of ten interstitial random cortical fields were captured at 20-fold magnification using a green optical filter (IF 550) and a high-resolution video camera (SONY CCD-iris) connected to a light microscope (LEITZ Laborlux S). The area occupied by collagen was measured using a computerized image analysis system (Fibrosis HRR, Master Diagnostica) as previously described 46 . The values obtained for tubulointerstitial fibrotic tissue were expressed in square micrometers and are represented in the figures relative to control kidneys.
Immunofluorescence. For quantification of fluorescence, images of 20 random fields were visualized and the number of tdTomato or SMA-positive cells was counted. Fields were observed at 400× magnification in a Leica DMR fluorescence microscope. In addition, five random fields were photographed with a Leica SP2 confocal scanning microscope (Leica Microsystems) and cells were counted.
Data analysis. Statistical analysis was performed using the GraphPad Prism software package. Results were expressed as mean ± s.e.m. (standard error of mean). Data were normally distributed and the variance between groups was not significantly different. Differences among groups were tested by one-way ANOVA or two-way ANOVA, followed up by Tukey's test as appropriate. Differences between two groups were tested using the Mann-Whitney test. Sample size was selected following the recommendations from the 'Organo Evaluador de Proyectos' (Committee for Preevaluation of Projects, University Miguel Hernandez) to calculate the size of the cohorts and following the requirements for the principles of the '3 Rs' (reduction, refinement and replacement). No randomization or blinding were performed, nor were there any exclusion criteria. 
